Volgen
anjo j veerman/ajp veerman
anjo j veerman/ajp veerman
professor emeritus of paediatrics
Geverifieerd e-mailadres voor amsterdamumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
A Holleman, MH Cheok, ML den Boer, W Yang, AJP Veerman, ...
New England Journal of Medicine 351 (6), 533-542, 2004
7232004
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia
GJL Kaspers, AJP Veerman, R Pieters, CH Van Zantwijk, LA Smets, ...
Blood, The Journal of the American Society of Hematology 90 (7), 2723-2729, 1997
3261997
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
RP Kuiper, E Waanders, VHJ Van Der Velden, SV Van Reijmersdal, ...
Leukemia 24 (7), 1258-1264, 2010
3222010
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants
R Pieters, ML Den Boer, M Durian, G Janka, K Schmiegelow, ...
Leukemia 12 (9), 1344-1348, 1998
3021998
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions
R Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, ...
2911990
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance
CM Zwaan, S Meshinchi, JP Radich, AJP Veerman, DR Huismans, ...
Blood 102 (7), 2387-2394, 2003
2852003
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)
AJ Veerman, WA Kamps, H van den Berg, E van den Berg, ...
The lancet oncology 10 (10), 957-966, 2009
279*2009
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia
E Klumper, R Pieters, AJ Veerman, DR Huismans, AH Loonen, K Hahlen, ...
2781995
White pulp compartments in the spleen of rats and mice: A light and electron microscopic study of lymphoid and non-lymphoid celltypes in T-and B-areas
AJP Veerman, W Van Ewijk
Cell and tissue research 156, 417-441, 1975
2621975
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia
R Pieters, DR Huismans, AH Loonen, AJP Veerman, K Hahlen, ...
The Lancet 338 (8764), 399-403, 1991
2401991
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood …
AJP Veerman, K Hählen, WA Kamps, EF Van Leeuwen, GAM De Vaan, ...
2391996
Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature
AI Buizer, LMJ de Sonneville, AJP Veerman
Pediatric blood & cancer 52 (4), 447-454, 2009
2272009
On the interdigitating cells in the thymus-dependent area of the rat spleen: a relation between the mononuclear phagocyte system and T-lymphocytes
AJP Veerman
Cell and Tissue Research 148, 247-257, 1974
2251974
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia
ML Den Boer, DO Harms, R Pieters, KM Kazemier, U Gobel, D Korholz, ...
Journal of clinical oncology 21 (17), 3262-3268, 2003
2112003
Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.
F Dong, LH Hoefsloot, AM Schelen, CA Broeders, Y Meijer, AJ Veerman, ...
Proceedings of the National Academy of Sciences 91 (10), 4480-4484, 1994
2081994
Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia
S Mostert, MN Sitaresmi, CM Gundy, null Sutaryo, AJP Veerman
Pediatrics 118 (6), e1600-e1606, 2006
2022006
Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity
AI Buizer, LMJ de Sonneville, MM van den Heuvel–Eibrink, AJP Veerman
Pediatric blood & cancer 45 (3), 281-290, 2005
2022005
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia
P Van Vlierberghe, M van Grotel, HB Beverloo, C Lee, T Helgason, ...
Blood 108 (10), 3520-3529, 2006
2012006
TEL/AML1 gene fusion is related to in vitro drug sensitivity forl-asparaginase in childhood acute lymphoblastic leukemia
NLR Woerden, R Pieters, AH Loonen, I Hubeek, E van Drunen, ...
Blood, The Journal of the American Society of Hematology 96 (3), 1094-1099, 2000
2012000
Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia
R Pieters, DR Huismans, A Leyva, AJP Veerman
Cancer letters 41 (3), 323-332, 1988
2011988
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20